TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncology

Social media site TikTok has become a common source of misinformation about gynecologic cancers. (Ohio State University Comprehensive Cancer Center, Gynecologic Oncology)

PGA Tour golfer Gary Woodland recently had surgery to remove a brain tumor, as did Louisiana State University football player Greg Brooks Jr. (CNN)

Kite and Gilead announced that the CAR T-cell therapy axicabtagene ciloleucel (Yescarta) produced complete metabolic responses in 71% of transplant-ineligible patients with relapsed/refractory large B-cell lymphoma.

Officials at Boston’s Brigham and Women’s Hospital were “stunned” by Dana-Farber Cancer Institute’s decision to drop the two centers’ partnership and enter into an agreement with Beth Israel Deaconess Medical Center to develop a freestanding cancer center. (Becker’s Hospital Review)

The Community Oncology Alliance announced its support of the Protecting Patient Access to Cancer and Complex Therapies Act, saying the bill (S. 2764, H.R. 5391) protects providers and patients.

The risk of breast cancer conferred by BRCA mutations may be lower than previously estimated. (eClinicalMedicine)

The American Society of Clinical Oncology’s Quality Care Symposium press program highlights three studies of strategies to reduce treatment-related toxicity and improve quality of life in patients with cancer.

A self-regulatory body in England publicly rebuked Roche for omitting important safety information on a drug-dosing webpage for entrectinib (Rozlytrek), a ROS1 and TRK inhibitor approved for ROS1-mutant non-small cell lung cancer and NTRK fusion-positive solid tumors. (FiercePharma)

An oncology nurse opens up about her side job as an NFL cheerleader. (Oncology Business Review)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow

Please enable JavaScript to view the

comments powered by Disqus.